Clozapine-induced hypersalivation and the alpha-2 adrenoceptor.
Szabadi
E
E
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D018341:Receptors, Adrenergic, alpha-2 / Q000187:drug effects*; D017448:Receptors, Dopamine D2 / Q000187:drug effects; D012798:Sialorrhea / Q000139:chemically induced*
D014150:Antipsychotic Agents; D018341:Receptors, Adrenergic, alpha-2; D017448:Receptors, Dopamine D2; D003024:Clozapine